{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:42:25Z","timestamp":1776145345938,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,11,1]],"date-time":"1993-11-01T00:00:00Z","timestamp":752112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[1993,11]]},"DOI":"10.1038\/ng1193-225","type":"journal-article","created":{"date-parts":[[2004,8,18]],"date-time":"2004-08-18T20:43:46Z","timestamp":1092861826000},"page":"225-229","source":"Crossref","is-referenced-by-count":420,"title":["Spontaneous and carcinogen\u2013induced tumorigenesis in p53\u2013deficient mice"],"prefix":"10.1038","volume":"5","author":[{"given":"Michele","family":"Harvey","sequence":"first","affiliation":[]},{"given":"Mark J.","family":"McArthur","sequence":"additional","affiliation":[]},{"suffix":"Jr.","given":"Charles A.","family":"Montgomery","sequence":"additional","affiliation":[]},{"given":"Janet S.","family":"Butel","sequence":"additional","affiliation":[]},{"given":"Allan","family":"Bradley","sequence":"additional","affiliation":[]},{"given":"Lawrence A.","family":"Donehower","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFng1193225_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/351453a0","volume":"351","author":"AJ Levine","year":"1991","unstructured":"Levine, A.J., Momand, J. & Finlay, C.A. The p53 tumour suppressor gene. Nature 351, 453\u2013456 (1991).","journal-title":"Nature"},{"key":"BFng1193225_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1126\/science.1905840","volume":"253","author":"M Hollstein","year":"1991","unstructured":"Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancers. Science 253, 49\u201353 (1991).","journal-title":"Science"},{"key":"BFng1193225_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gcc.2870040102","volume":"4","author":"C Caron de Fromentel","year":"1992","unstructured":"Caron de Fromentel, C. & Soussi, T. TP53 tumor suppressor gene: A model for investigating human mutagenesis. Genes, Chrom. Cancer 4, 1\u201315 (1992).","journal-title":"Genes, Chrom. Cancer"},{"key":"BFng1193225_CR4","first-page":"174","volume":"88","author":"F Chang","year":"1993","unstructured":"Chang, F., Syrjanen, S., Kurvinen, K. & Syrjanen, K. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am. j. Gastroenterol. 88, 174\u2013186 (1993).","journal-title":"Am. j. Gastroenterol."},{"key":"BFng1193225_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/342705a0","volume":"342","author":"JM Nigro","year":"1989","unstructured":"Nigro, J.M. et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 342, 705\u2013708 (1989).","journal-title":"Nature"},{"key":"BFng1193225_CR6","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.1073\/pnas.84.21.7716","volume":"84","author":"H Masuda","year":"1987","unstructured":"Masuda, H., Miller, C., Koeffler, H.P., Battifora, H., Cline, M.J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. natn. Acad. Sci. U.S.A. 84, 7716\u20137719 (1987).","journal-title":"Proc. natn. Acad. Sci. U.S.A."},{"key":"BFng1193225_CR7","first-page":"4721","volume":"51","author":"RL Saylors","year":"1991","unstructured":"Saylors, R.L. et al. Infrequent p53 gene mutations in medulloblastomas. Cancer Res. 51, 4721\u20134723 (1991).","journal-title":"Cancer Res."},{"key":"BFng1193225_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1365-2141.1992.tb08253.x","volume":"81","author":"C Preudhomme","year":"1992","unstructured":"Preudhomme, C. et al. Rare occurrence of p53 gene mutations in multiple myeloma. Br. J. Haematol. 81, 440 (1992).","journal-title":"Br. J. Haematol."},{"key":"BFng1193225_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2141.1992.tb08263.x","volume":"81","author":"K Tsushita","year":"1992","unstructured":"Tsushita, K., Hotta, T., Ichikawa, A. & Saito, H. Mutation of p53 gene does not play a critical role in myelodysplastic syndrome and its transformation to acute leukaemia. Br. J. Haematol. 81, 456 (1992).","journal-title":"Br. J. Haematol."},{"key":"BFng1193225_CR10","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.1073\/pnas.89.15.7262","volume":"89","author":"U Moll","year":"1992","unstructured":"Moll, U., Riou, G. & Levine, A.J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. natn. Acad. Sci. U.S.A. 89, 7262\u20137266 (1992).","journal-title":"Proc. natn. Acad. Sci. U.S.A."},{"key":"BFng1193225_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233\u20131238 (1990).","journal-title":"Science"},{"key":"BFng1193225_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/348747a0","volume":"348","author":"S Srivastava","year":"1990","unstructured":"Srivastava, S., Zou, Z., Pirollo, K., Blattner, W. & Chang, E. Germ-line transmission of a mutated p53 gene in a cancerprone family with Li-Fraumeni syndrome. Nature 348, 747\u2013749 (1990).","journal-title":"Nature"},{"key":"BFng1193225_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM199205143262001","volume":"326","author":"J Toguchida","year":"1992","unstructured":"Toguchida, J. et al. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. New Engl. J. Med. 326, 1301\u20131308 (1992).","journal-title":"New Engl. J. Med."},{"key":"BFng1193225_CR14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJM199205143262002","volume":"326","author":"D Malkin","year":"1992","unstructured":"Malkin, D. et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. New Engl. J. Med. 326, 1309\u20131315 (1992).","journal-title":"New Engl. J. Med."},{"key":"BFng1193225_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(91)90428-2","volume":"66","author":"Y Ben-David","year":"1991","unstructured":"Ben-David, Y. & Bernstein, A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66, 831\u2013834 (1991).","journal-title":"Cell"},{"key":"BFng1193225_CR16","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1128\/MCB.9.9.3982","volume":"9","author":"A Lavigueur","year":"1989","unstructured":"Lavigueur, A. et al. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Molec. cell. Biol. 9, 3982\u20133991 (1989).","journal-title":"Molec. cell. Biol."},{"key":"BFng1193225_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0092-8674(91)90384-B","volume":"65","author":"J Milner","year":"1991","unstructured":"Milner, J. & Medcalf, E.A. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65, 765\u2013774 (1991).","journal-title":"Cell"},{"key":"BFng1193225_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1589764","volume":"256","author":"S Kern","year":"1992","unstructured":"Kern, S. et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827\u2013830 (1992).","journal-title":"Science"},{"key":"BFng1193225_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/358083a0","volume":"358","author":"G Farmer","year":"1992","unstructured":"Farmer, G. et al. Wild-type p53 activates transcription in vitro. Nature 358, 83\u201386 (1992).","journal-title":"Nature"},{"key":"BFng1193225_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215\u2013221 (1992).","journal-title":"Nature"},{"key":"BFng1193225_CR21","first-page":"1213","volume":"41","author":"NK Clapp","year":"1968","unstructured":"Clapp, N.K., Craig, A.W. & Toya, R.E. Sr. Pulmonary and hepatic oncogenesis during treatment of male RF mice with dimethylnitrosamine. J. natn Cancer Inst. 41, 1213\u20131221 (1968).","journal-title":"J. natn Cancer Inst."},{"key":"BFng1193225_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/0092-8674(92)90243-6","volume":"70","author":"L Livingstone","year":"1992","unstructured":"Livingstone, L. et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923\u2013935 (1992).","journal-title":"Cell"},{"key":"BFng1193225_CR23","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0092-8674(92)90244-7","volume":"70","author":"Y Yin","year":"1992","unstructured":"Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C. & Wahl, G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937\u2013948 (1992).","journal-title":"Cell"},{"key":"BFng1193225_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0092-8674(92)90593-2","volume":"71","author":"M Kastan","year":"1992","unstructured":"Kastan, M. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587\u2013597 (1992).","journal-title":"Cell"},{"key":"BFng1193225_CR25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/362847a0","volume":"362","author":"SW Lowe","year":"1993","unstructured":"Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. & Jacks, T. p53 is required for radiation-induced apoptosis. Nature 362, 847\u2013849 (1993).","journal-title":"Nature"},{"key":"BFng1193225_CR26","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/362849a0","volume":"362","author":"AR Clarke","year":"1993","unstructured":"Clarke, A.R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849\u2013852 (1993).","journal-title":"Nature"},{"key":"BFng1193225_CR27","first-page":"2144","volume-title":"Cancer Medicine","author":"TJ Triche","year":"1993","unstructured":"Triche, T.J. Unique features of childhood cancer. In Cancer Medicine, 3rd edn, (eds Holland, J.F. et al.) 2144\u20132152 (Lea & Febiger, Malvern, Philadelphia, 1993)."},{"key":"BFng1193225_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S0022-3476(74)80511-1","volume":"85","author":"RW Miller","year":"1974","unstructured":"Miller, R.W. & Dalager, B. U.S. childhood deaths by cell type. J. Pediat. 85, 664 (1974).","journal-title":"J. Pediat."},{"key":"BFng1193225_CR29","first-page":"101","volume-title":"International Incidence of Childhood Cancer","author":"DM Parkin","year":"1988","unstructured":"Parkin, D.M. et al. Results from Contributing Centers\u2014List of Tables. In International Incidence of Childhood Cancer, No. 87, 101\u2013107 (Oxford University Press, 1988)."},{"key":"BFng1193225_CR30","first-page":"5518","volume":"47","author":"MF Hansen","year":"1987","unstructured":"Hansen, M.F. & Cavenee, W.K. Genetics of cancer predisposition. Cancer Res. 47, 5518\u20135527 (1987).","journal-title":"Cancer Res."},{"key":"BFng1193225_CR31","first-page":"283","volume":"10","author":"P Fournier","year":"1990","unstructured":"Fournier, P. Biotransformation of dimethylnitrosamine. J. Toxicol. Clin. Exp. 10, 283\u2013296 (1990).","journal-title":"J. Toxicol. Clin. Exp."},{"key":"BFng1193225_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/path.1711580314","volume":"158","author":"DJ Pritchard","year":"1989","unstructured":"Pritchard, D.J. & Butler, W.H. Apoptosis\u2014The mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity. J. Pathol. 158, 253\u2013260 (1989).","journal-title":"J. Pathol."},{"key":"BFng1193225_CR33","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0092-8674(93)90461-X","volume":"74","author":"C Kemp","year":"1993","unstructured":"Kemp, C., Donehower, L.A., Bradley, A. & Balmain, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74, 813\u2013822 (1993).","journal-title":"Cell"},{"key":"BFng1193225_CR34","first-page":"2363","volume":"6","author":"PA Burns","year":"1991","unstructured":"Burns, P.A. et al. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene 6, 2363\u20132369 (1991).","journal-title":"Oncogene"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng1193-225","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1193-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1193-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:18:55Z","timestamp":1684444735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng1193-225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["BFng1193225"],"URL":"https:\/\/doi.org\/10.1038\/ng1193-225","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}